Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Recursion Pharmaceuticals Inc Cl A (RXRX)

Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Recursion Completes Merger with Exscientia, Launches Comprehensive AI-Enabled Drug Discovery Portfolio Quiver Quantitative, Inc. - Wed Nov 20, 4:16PM CST

Recursion announces post-combination technology portfolio with over 30 drug programs, aiming to enhance AI-driven drug discovery efficiency.Quiver AI SummaryRecursion has announced the completion of its...

RXRX : 5.70 (-5.63%)
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery GlobeNewswire - Wed Nov 20, 6:00AM CST

RXRX : 5.70 (-5.63%)
Recursion and Exscientia Shareholders Approve the Proposed Combination GlobeNewswire - Wed Nov 13, 8:08AM CST

RXRX : 5.70 (-5.63%)
Recursion Announces the Release of OpenPhenom-S/16 in Google Cloud’s Model Garden GlobeNewswire - Tue Nov 12, 3:54PM CST

RXRX : 5.70 (-5.63%)
Inside the AI-Healthcare Boom: Breakthroughs in Diagnostics and Personalized Treatment BayStreet.ca - Tue Nov 12, 9:19AM CST

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – A recent World Economic Forum report highlights AI's potential to ease the strain on healthcare systems...

MSFT : 413.07 (-0.38%)
NVDA : 143.40 (-1.71%)
TWST : 41.89 (+1.90%)
AVAI : 0.5300 (+1.92%)
ABSI : 2.64 (-1.49%)
RXRX : 5.70 (-5.63%)
EXAI : 4.84 (+3.20%)
Recursion Pharmaceuticals: Q3 Earnings Snapshot AP - Wed Nov 6, 4:57PM CST

Recursion Pharmaceuticals: Q3 Earnings Snapshot

RXRX : 5.70 (-5.63%)
Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results GlobeNewswire - Wed Nov 6, 3:15PM CST

RXRX : 5.70 (-5.63%)
Is Recursion Pharmaceuticals a Millionaire-Maker Stock? Motley Fool - Sat Nov 2, 8:45AM CDT

In an environment where the typical small biotech name is riskier than not, this one is curiously different.

RXRX : 5.70 (-5.63%)
Recursion to Report Third Quarter 2024 Business Updates and Financial Results on November 6th GlobeNewswire - Wed Oct 30, 7:22AM CDT

RXRX : 5.70 (-5.63%)
3 Key Trends That Are Bullish for Recursion Pharmaceuticals Stock Motley Fool - Sat Oct 26, 8:00AM CDT

This company stands to benefit from a shifting pharmaceutical industry landscape.

RXRX : 5.70 (-5.63%)

Barchart Exclusives

1 EV Stock Under $10 With 25% Upside Potential Barchart - 28 minutes ago
This charging stock has been under heavy pressure lately amid concerns over the fate of EV tax credits. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot